Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

by Scott M. Grundy
Save 75% Save 75%
Current price ₹5,515.00
Original price ₹22,059.00
Original price ₹22,059.00
Original price ₹22,059.00
(-75%)
₹5,515.00
Current price ₹5,515.00

Ships in 1-2 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9780824782160
  • Binding: Hardcover
  • Subject: Medical, Nursing and Health Sciences
  • Publisher: T&F
  • Publisher Imprint: Mar Dekker
  • Publication Date:
  • Pages: 352
  • Original Price: GBP 180.0
  • Language: English
  • Edition: N/A
  • Item Weight: 604 grams
  • BISAC Subject(s): Nutrition

About the Book Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States.
This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies presented in Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence promote cholesterol reduction as a highly successful means of preventing heart disease in various populations.
Investigates past, current, and upcoming controlled clinical trials of cholesterol-reduction therapies, comparing effects of statins and bile acid sequestrants to triglyceride-lowering drugs and antioxidants.
Written by more than 25 distinguished international researchers, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

  • highlights historical studies of dietary trials designed to reduce CHD
  • covers tests of HMG CoA reductase inhibitors for patients with and without CHD
  • illuminates CHD risk factors such as diabetes, hypertension, obesity, and smoking
  • explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors
  • reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol
  • and more!
    Containing over 700 instructive tables, drawings, photographs, and bibliographic citations, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists, pharmacologists, and upper-level undergraduate, graduate, and medical school students in these disciplines.
  • Trusted for over 48 years

    Family Owned Company

    Secure Payment

    All Major Credit Cards/Debit Cards/UPI & More Accepted

    New & Authentic Products

    India's Largest Distributor

    Need Support?

    Whatsapp Us